Author

Xinyi Bao

Wenzhou-Kean University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:human· 1 Approach:simulation· 1 Approach:statistical model· 1

Frequent Co-Authors

Chengxu Xie· 3 shared Lifang ZhangiD· 3 shared Mojtaba TabandehiD· 3 shared Vishwa DeepakiD· 3 shared Farwa Basit· 2 shared Heriberto VélëziD· 2 shared Xiaohan Li· 2 shared Yili DingiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersPharmacology & Toxicology

Chengxu Xie

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Asarinin Inhibits RANKL-Induced Osteoclast Differentiation by Targeting the p38/ERK-c-Fos-NFATc1 Axis

Lifang Zhang, Chengxu Xie, Xinyi Bao, Xiaohan Li, Heriberto Vélëz, Farwa Basit, Yili Ding, Mojtaba Tabandeh, Vishwa Deepak

This study shows asarinin inhibits osteoclast differentiation by blocking the p38/ERK-c-Fos-NFATc1 pathway in RANKL-stimulated cells.

International Journal of Molecular Sciences · Aug 11, 2026Peer-reviewedPharmacology & Toxicology

IKKβ as a putative non-covalent and quinone-mediated covalent target of 4-methylcatechol in RANKL/NF-κB signaling: a combined computational and experimental analysis

Chengxu Xie, Lifang Zhang, Xinyi Bao, Xiaohan Li, Yili Ding, Mojtaba Tabandeh, Farwa Basit, Heriberto Vélëz, Santosh Kumar, Vishwa Deepak

This study investigates how 4-methylcatechol affects RANKL-induced osteoclastogenesis by targeting IKKβ through non-covalent and covalent mechanisms.

bioRxiv · Aug 4, 2026 · PreprintPharmacology & Toxicology

Methyl Carnosate, a Carnosic Acid Derivative, Attenuates Osteoclastogenesis via Modulation of RANKL-Induced NF-κB Activity

Lifang Zhang, Chengxu Xie, Xinyi Bao, Mojtaba Tabandeh, Vishwa Deepak

The paper identifies methyl carnosate as a potent inhibitor of RANKL-induced osteoclastogenesis with an IC50 of 1.2 M, showing greater efficacy than carnosic acid.

Frontiers in Pharmacology · Jun 3, 2026Peer-reviewedPharmacology & Toxicology